Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Artificial Solutions
Technology
Partnership with UiPath, a global RPA leader
By
Milan Radia
13 May 2020
Volta Finance
Financials
Q&A with Hardman analyst
By
Mark Thomas
12 May 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Shield Therapeutics Plc
Life Sciences
Reassuring trading update
By
Dr Martin Hall
11 May 2020
Financials
Platform potential
By
Jason Streets
11 May 2020
The Monthly: May 2020
04 May 2020
Are the public markets closing to smaller companies?
By
Keith Hiscock
01 May 2020
Artificial Solutions
Technology
Conversational artificial intelligence made real
By
Milan Radia
28 Apr 2020
Arix Bioscience
Life Sciences
Resetting the stage
By
Dr Martin Hall
23 Apr 2020
City of London Investment Group
Financials
Handling challenging markets well
By
Dr Brian Moretta
22 Apr 2020
Surface Transforms
Industrial
High visibility for 2021 onwards; equity raise
By
Mike Foster
17 Apr 2020
The Hardman & Co Lockdown Compendium
10 Apr 2020
Prev
1
...
38
39
40
41
42
...
78
Next
